1-9 of 9
Friederike Schneider
Close
Sort by
Journal Articles

Activating FLT3 Mutations Display a Wide Range Of Transforming Potential and a Characteristic Pathway Profile Associated With Prognosis In Acute Myeloid Leukemia

Hanna Janke, Friederike Schneider, MD, Daniela Schumacher, Tobias Herold, MD, Hopfner Karl-Peter, PhD, Stephanie Schneider, PhD, Wolfgang E. Berdel, MD, Thomas Büchner, MD, Bernhard J. Woermann, MD, Marion Subklewe, MD, Stefan K. Bohlander, MD, Wolfgang Hiddemann, MD, Harald Polzer, PhD, Karsten Spiekermann, MD
Journal: Blood
Blood (2013) 122 (21): 1312.
https://doi.org/10.1182/blood.V122.21.1312.1312
Published: 2013
Journal Articles

GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia

Philipp A. Greif, Annika Dufour, Nikola P. Konstandin, Bianka Ksienzyk, Evelyn Zellmeier, Belay Tizazu, Jutta Sturm, Tobias Benthaus, Tobias Herold, Marjan Yaghmaie, Petra Dörge, Karl-Peter Hopfner, Andreas Hauser, Alexander Graf, Stefan Krebs, Helmut Blum, Purvi M. Kakadia, Stephanie Schneider, Eva Hoster, Friederike Schneider, Martin Stanulla, Jan Braess, Maria Cristina Sauerland, Wolfgang E. Berdel, Thomas Büchner, Bernhard J. Woermann, Wolfgang Hiddemann, Karsten Spiekermann, Stefan K. Bohlander
Journal: Blood
Blood (2012) 120 (2): 395–403.
https://doi.org/10.1182/blood-2012-01-403220
Published: 2012
Includes: Supplemental data
Journal Articles

The FLT3 ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype

Brief Report
Friederike Schneider, Eva Hoster, Michael Unterhalt, Stephanie Schneider, Annika Dufour, Tobias Benthaus, Gudrun Mellert, Evelyn Zellmeier, Purvi M. Kakadia, Stefan K. Bohlander, Michaela Feuring-Buske, Christian Buske, Jan Braess, Achim Heinecke, Maria C. Sauerland, Wolfgang E. Berdel, Thomas Büchner, Bernhard J. Wörmann, Wolfgang Hiddemann, Karsten Spiekermann
Journal: Blood
Blood (2012) 119 (19): 4383–4386.
https://doi.org/10.1182/blood-2010-12-327072
Published: 2012
Includes: Supplemental data
Journal Articles

A New Molecular and Clinical Prognostic Score for Risk Stratification in CN-AML.

Friederike Schneider, Annika Dufour, Tobias Benthaus, Stephanie Schneider, Gudrun Mellert, Evelyn Zellmeier, Stefan K Bohlander, Michael Unterhalt, Michaela Feuring-Buske, Christian Buske, Jan Braess, Maria Cristina Sauerland, Achim Heinecke, Wolfgang Berdel, Thomas Buechner, Bernhard Wörmann, Wolfgang Hiddemann, Karsten Spiekermann, Eva Hoster
Journal: Blood
Blood (2009) 114 (22): 2635.
https://doi.org/10.1182/blood.V114.22.2635.2635
Published: 2009
Journal Articles

Elevated PRV-1 Plasma Levels Constitute An Independent Risk Factor for the Development of Transient Ischemic Attacks in Essential Thrombocythemia.

Sven Schwemmers, Edith Maerz, Heinz Gisslinger, MD, Friederike Schneider, Heike L. Pahl, PhD
Journal: Blood
Blood (2009) 114 (22): 1900.
https://doi.org/10.1182/blood.V114.22.1900.1900
Published: 2009
Journal Articles

NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS)

Brief Report
Friederike Schneider, Eva Hoster, Michael Unterhalt, Stephanie Schneider, Annika Dufour, Tobias Benthaus, Gudrun Mellert, Evelin Zellmeier, Stefan K. Bohlander, Michaela Feuring-Buske, Christian Buske, Jan Braess, Susanne Fritsch, Achim Heinecke, Maria C. Sauerland, Wolfgang E. Berdel, Thomas Buechner, Bernhard J. Woermann, Wolfgang Hiddemann, Karsten Spiekermann
Journal: Blood
Blood (2009) 113 (21): 5250–5253.
https://doi.org/10.1182/blood-2008-09-172668
Published: 2009
Includes: Supplemental data
Journal Articles

Age-Dependent Frequencies of NPM-1/FLT3-ITD Mutations in Patients with Normal Karyotype AML

Friederike Schneider, Eva Hoster, Michael Unterhalt, Stephanie Schneider, Annika Dufour, Tobias Benthaus, Gudrun Mellert, Evelyn Zellmeier, Stefan K. Bohlander, Michaela Feuring-Buske, Christian Buske, Jan Braess, Achim Heinecke, Maria C. Sauerland, Wolfgang E. Berdel, Thomas Buechner, Wolfgang Hiddemann, Karsten Spiekermann
Journal: Blood
Blood (2008) 112 (11): 2531.
https://doi.org/10.1182/blood.V112.11.2531.2531
Published: 2008
Journal Articles

Prognostic Impact of Clinical and Molecular Markers in Normal Karyotype AML-Results from the AMLCG 2000 Trial.

Friederike Schneider, Eva Hoster, PhD, Marietta Rottenkolber, PhD, Stephanie Schneider, PhD, Annika Dufour, PhD, Tobias Benthaus, Gudrun Mellert, Evelyn Zellmeier, Stefan K. Bohlander, MD, Michael Unterhalt, MD, Michaela Feuring-Buske, MD, Christian Buske, MD, Jan Braess, MD, Achim Heinecke, PhD, Wolfgang E. Berdel, MD, Thomas Buechner, MD, Wolfgang Hiddemann, MD, Karsten Spiekermann, MD
Journal: Blood
Blood (2007) 110 (11): 3482.
https://doi.org/10.1182/blood.V110.11.3482.3482
Published: 2007
Journal Articles

FLT3-ITD but Not FLT3-TKD Mutations Have Major Prognostic Impact in Normal Karyotype AML.

Stephanie Schneider, PhD, Friederike Schneider, Annika Dufour, PhD, Gudrun Mellert, Evelyn Zellmeier, Jan Braess, MD, Stefan K. Bohlander, MD, Michaela Feuring-Buske, MD, Christian Buske, MD, Susanne Fritsch, Achim Heinecke, PhD, Maria C. Sauerland, PhD, Eva Hoster, PhD, Michael Unterhalt, MD, Wolfgang E. Berdel, MD, Bernhard J. Wormann, MD, Thomas Buechner, MD, Wolfgang Hiddemann, MD, Karsten Spiekermann, MD
Journal: Blood
Blood (2007) 110 (11): 3486.
https://doi.org/10.1182/blood.V110.11.3486.3486
Published: 2007